NEW YORK, May 23, 2026, 13:04 (EDT)
- Bioceres dropped 4.85% to finish Friday near 41 cents. Major U.S. indexes ended higher.
- The Nasdaq is closed for the weekend and for Memorial Day on Monday. Regular trading will not take place.
- The stock is still below Nasdaq’s $1 minimum bid, with investors focused on the latest debt and restructuring news.
Bioceres Crop Solutions Corp. slipped ahead of the long holiday weekend in the U.S. The stock, listed on Nasdaq, was trading close to 41 cents at the end of a quiet, volatile week.
The timing is a factor. U.S. trading for BIOX stays halted until Tuesday, with Nasdaq closed for the weekend and again on Monday, May 25, for Memorial Day. Normal hours for Nasdaq are 9:30 a.m. to 4 p.m. Eastern on regular trading days.
BIOX ended Friday at $0.41, falling 4.85%. About 122,980 shares traded hands, well under the 326,670 average from Google Finance. The market cap was listed at $26.1 million. Shares traded between a 52-week low of $0.35 and a high of $5.18.
The stock trailed the market. The S&P 500 added 0.4% on Friday and finished the week up 0.9%. The Dow closed 0.6% higher Friday, gaining 2.1% over the week. The Nasdaq Composite ticked up 0.2% on Friday and 0.5% for the week, AP market data showed.
Bioceres moved around this week, starting Monday at $0.44 before sliding to $0.42 on Tuesday. Shares were back at $0.43 by Wednesday, traded flat at $0.44 Thursday, then dropped again to $0.41 Friday. For Friday, the stock stayed inside a tight $0.41 to $0.44 range.
This isn’t just about how the stock trades. Bioceres said in March that Nasdaq flagged the company because shares were under the $1 minimum bid price for listing. Now Bioceres has until Sept. 14, 2026 to get back above $1 for at least 10 sessions in a row.
Bioceres didn’t shake off uncertainty with its latest results. The company posted fiscal third-quarter revenue of $39.4 million, a drop of 23% from last year. Net loss came in at $10.0 million. Adjusted EBITDA was negative $0.6 million; that strips out interest, taxes, depreciation, amortization, and other items the company excludes.
Bioceres CEO Federico Trucco called the last quarter a “period of transition and operational refocusing,” saying management is focused on “stabilizing the business” in the wake of the Pro Farm foreclosure and the dispute around it. The company said it’s working on debt-reprofiling, which would change repayment timing or terms, and is seeking a voluntary bond maturity extension in Argentina. Bioceres Crop Solutions
Bioceres is sticking with its core crop protection, seeds and crop nutrition business. The company says its platform spans seed technologies, microbial ag inputs, and crop nutrition and protection products. That lineup features the HB4 drought-tolerant seed program.
Bigger ag-input stocks mostly showed gains, but moves were uneven. Google Finance put Corteva up 0.66% on Friday. Mosaic added 2.60%. Nutrien was down 0.16%. These are all much larger companies, so it’s a rough sector comparison, not a valuation peer.
The risk is still clear. Bioceres needs to get its share price above Nasdaq’s $1 mark, win back investor confidence after the Pro Farm mess, and deliver stronger cash flow from what’s left of the business. If not, the stock could stay choppy and see more heat over its listing.
Short trading week means a slow start. For BIOX, eyes are on whether buyers step back in following the Memorial Day break. Bigger question for the stock is if management’s restructuring plans show up as real balance-sheet gains and more stable operating numbers.
